Evid Invest
Who owns TRDAWhat TRDA owns — n/a

Who owns Entrada Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of TRDA from SEC Form 13F filings across 132 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 132 institutions disclosed 30.9M shares of Entrada Therapeutics, Inc. worth $196.2M — about 73% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.

132

13F holders

$196.2M

value, 2026 filers

73%

of shares outstanding (30.9M sh)

18

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TRDA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BAKER BROS. ADVISORS LP5.1M$32.2M0.2%12%0.0%
25AM Venture Management, LLC3.8M$24.0M8.1%8.9%-6.7%
3BlackRock, Inc.3.2M$20.6M0.0%7.6%+25.3%
4Merck & Co., Inc.1.7M$11.0M1.3%4.1%0.0%
5Trails Edge Capital Partners, LPNEW1.4M$9.1M1.3%3.4%new
6VANGUARD CAPITAL MANAGEMENT LLC1.3M$8.1M0.0%3%0.0%
7TCG Crossover Management, LLC1.1M$6.7M0.2%2.5%0.0%
8WELLINGTON MANAGEMENT GROUP LLP954,419$6.1M0.0%2.3%0.0%
9StepStone Group LP761,277$4.8M0.3%1.8%0.0%
10GEODE CAPITAL MANAGEMENT, LLC708,490$4.5M0.0%1.7%-1.2%
11ACADIAN ASSET MANAGEMENT LLC648,973$4.1M0.0%1.5%+61.9%
12UBS Group AG624,220$4.0M0.0%1.5%+1401.8%
13AQR CAPITAL MANAGEMENT LLC623,874$4.0M0.0%1.5%-10.8%
14STATE STREET CORP589,101$3.7M0.0%1.4%-1.3%
15JPMORGAN CHASE & CO506,591$3.2M0.0%1.2%+2.0%
16CITADEL ADVISORS LLC461,737$2.9M0.0%1.1%+17.1%
17MORGAN STANLEY386,243$2.5M0.0%0.9%+101.5%
18MILLENNIUM MANAGEMENT LLC344,603$2.2M0.0%0.8%-54.9%
19DIMENSIONAL FUND ADVISORS LP344,005$2.2M0.0%0.8%-8.5%
20NORTHERN TRUST CORP298,840$1.9M0.0%0.7%-3.6%
21GOLDMAN SACHS GROUP INC298,172$1.9M0.0%0.7%+68.1%
22Lynx1 Capital Management LP278,606$1.8M0.3%0.7%+56.0%
23J. Goldman & Co LPNEW268,081$1.7M0.0%0.6%new
24GSA CAPITAL PARTNERS LLP262,682$1.7M0.1%0.6%+198.5%
25VANGUARD PORTFOLIO MANAGEMENT LLC261,475$1.7M0.0%0.6%+2.9%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month